A new study published in the Journal of Alzheimer’s Disease presents an innovative method that may detect signs of Alzheimer’s disease before symptoms appear—using a simple, noninvasive eye ...

For now there is no drug treatment for ASD, but Roche has been testing a vasopressin V1A receptor inhibitor called balovaptan (RG7314) which failed to hit the mark in a phase 2 trial but has been ...

Tests revealed he had geographic atrophy ... Normandin joined Syfovre's clinical trial to test the drug on his right eye and said his right eye has been stabilized to the point where he can "get ...

The biotech, which raised $540 million in an initial public offering last year, is pitching the medicine as a potential challenger to Amgen’s blockbuster eye drug Tepezza.

Eyenovia to End Eye Drug Study, Cut 50% of Its Workforce. More. Reuters. File Photo: A patient undergoes an eye exam in Inglewood, California August 11, 2009. REUTERS/Mario Anzuoni/File Photo ...